Controlled Release
Zogenix Licenses Exclusive U.S. Commercial Rights for Late Stage, Controlled-Release, Opioid Product from Elan
Published in Healthcare Finance, Tax and Law Weekly, December 12th, 2007
Zogenix, Inc. ("Zogenix"), a private, specialty pharmaceutical company, announced they have entered into a License Agreement under which Zogenix has been granted exclusive US rights from an affiliate of Elan Corporation, plc (NYSE:ELN) ("Elan") to develop and commercialize a late stage, controlled-release opioid for the treatment of pain. The product, which incorporates Elan's proprietary SODAS(R) Technology, has previously demonstrated in a Phase 2 clinical trial a clinically acceptable safety profile and a reduction in pain intensity for chronic moderate to severe osteoarthritis pain patients across multiple dosage strengths.
Under the terms of the Agreement, Elan...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- Addiction Medicine
New addiction medicine data have been reported by D.A. Highfield and co-authors - Adverse Drug Reactions
Vermont Requires Reporting of NQF Serious Reportable Events - Aging
Global Health and Global Aging Presents Information about Leadership and Governance Challenges as Well as Insights about Aging in Different Cultures and Countries in All Regions of the World - Alcoholism
Both alcohol dependence and conduct disorder contribute to having a high number of sex partners - Alexian Brothers Hospital Network
New Study Shows More Than Half of All Americans are Unable to Access Vital Records Quickly During an Emergency - Alliance Imaging, Inc.
Alliance Imaging Announces Proposed Private Offering of $125 Million of Senior Subordinated Notes - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
